UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Gates Industrial Corporation Ltd.
GTES
$7.19B
| $1.63M | ﹤0.01% |
142,631
+16,914
| +13% | +$186K |
|
1577
SSR Mining
SSRM
$6.4B
| $1.63M | ﹤0.01% |
103,729
+45,136
| +77% | +$661K |
|
1578
Sylvamo
SLVM
$1.6B
| $1.62M | ﹤0.01% |
33,418
+5,091
| +18% | +$244K |
|
1579
JetBlue
JBLU
$2.13B
| $1.62M | ﹤0.01% |
250,420
+16,014
| +7% | +$117K |
|
|
CERE
1580
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.62M | ﹤0.01% |
51,316
+1,348
| +3% | +$38K |
|
1581
Urban Outfitters
URBN
$6.81B
| $1.61M | ﹤0.01% |
67,590
+13,493
| +25% | +$336K |
|
1582
Matthews International
MATW
$717M
| $1.61M | ﹤0.01% |
52,823
| – | – |
|
1583
HNI Corp
HNI
$3.54B
| $1.61M | ﹤0.01% |
56,514
| – | – |
|
|
SAGE
1584
DELISTED
Sage Therapeutics
SAGE
| $1.61M | ﹤0.01% |
42,092
+2,288
| +6% | +$87.4K |
|
|
PWSC
1585
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $1.61M | ﹤0.01% |
69,543
-461
| -0.7% | -$9.02K |
|
|
CCRN
1586
DELISTED
Cross Country Healthcare
CCRN
| $1.6M | ﹤0.01% |
60,344
-5,683
| -9% | -$185K |
|
1587
Sally Beauty Holdings
SBH
$1.57B
| $1.6M | ﹤0.01% |
127,949
-741
| -0.6% | -$9.1K |
|
1588
DoubleVerify
DV
$2.03B
| $1.6M | ﹤0.01% |
72,930
+14,298
| +24% | +$372K |
|
1589
TTM Technologies
TTMI
$13.7B
| $1.6M | ﹤0.01% |
106,185
| – | – |
|
1590
Kforce
KFRC
$1.04B
| $1.6M | ﹤0.01% |
29,203
| – | – |
|
1591
Axos Financial
AX
$5.63B
| $1.6M | ﹤0.01% |
41,889
| – | – |
|
1592
Monro
MNRO
$368M
| $1.6M | ﹤0.01% |
35,348
-3,436
| -9% | -$159K |
|
|
ACH
1593
Accendra Health
ACH
$107M
| $1.59M | ﹤0.01% |
81,413
+8,089
| +11% | +$158K |
|
1594
Provident Financial Services
PFS
$3.17B
| $1.58M | ﹤0.01% |
74,150
+7,955
| +12% | +$171K |
|
1595
Standex International
SXI
$3.98B
| $1.58M | ﹤0.01% |
15,460
| – | – |
|
1596
Central Garden & Pet Co Class A
CENTA
$2.39B
| $1.57M | ﹤0.01% |
54,989
| – | – |
|
1597
OSI Systems
OSIS
$3.83B
| $1.57M | ﹤0.01% |
19,774
+1,390
| +8% | +$113K |
|
1598
Establishment Labs
ESTA
$2.21B
| $1.56M | ﹤0.01% |
23,785
-949
| -4% | -$57.3K |
|
1599
Q2 Holdings
QTWO
$3.96B
| $1.56M | ﹤0.01% |
58,037
-3,583
| -6% | -$100K |
|
1600
Photronics
PLAB
$1.89B
| $1.56M | ﹤0.01% |
92,444
-5,095
| -5% | -$86.9K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.